Skip to main content
Annals of Oncology logoLink to Annals of Oncology
. 2018 Jan 2;29(7):1606. doi: 10.1093/annonc/mdx801

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

L A Dunn, M G Fury, H Xiao, S S Baxi, E J Sherman, S Korte, C Pfister, S Haque, N Katabi, A L Ho, D G Pfister
PMCID: PMC6888018  PMID: 29300804

Ann Oncol 2017; 28: 2533–2538 (doi: 10.1093/annonc/mdx346)

In the original article, the funding information contained the wrong grant number: CA008747, rather than CA008748. This has now been corrected.


Articles from Annals of Oncology are provided here courtesy of Oxford University Press

RESOURCES